share_log
Reuters ·  Jul 30 03:30
European Medicines Agency (EMA) Approves Bio-Thera Solutions' Bat1706 (Avzivi®, Bevacizumab), a Biosimilar Referencing Avastin®
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment